Abstract
We assessed the use of antileukotrienes for treating adenotonsillar hypertrophy. We reviewed the current literature on the anatomy of adenotonsillar tissue, adenotonsillar hypertrophy/hyperplasia (and the associated pathophysiology and symptoms), and the effects of antileukotrienes used to treat adenotonsillar hypertrophy. Leukotrienes (LTs) are inflammatory mediators produced by a number of cell types, including mast cells, eosinophils, basophils, macrophages, and monocytes. There are several types (e.g., LTA4, LTB4, LTC4, LTD4, and LTE4). By competitive binding to the cysLT1 receptor, LT-receptor antagonist drugs such as montelukast, zafirlukast, and pranlukast block the effects of cySHLTs, improving the symptoms of some chronic respiratory diseases. High numbers of LT receptors have been found in the tonsils of children with obstructive sleep apnea. Antileukotrienes reduce the apnea–hypopnea index and adenotonsillar inflammation. Antileukotrienes may be useful for children with adenotonsillar hypertrophy due to their anti-inflammatory effects, which help to reduce adenotonsillar inflammation.
Similar content being viewed by others
References
Scadding G (2010) Non-surgical treatment of adenoidal hypertrophy: the role of treating IgE-mediated inflammation. Pediatr Allergy Immunol 21(8):1095–1106
Shine NP, Coates HL, Lannigan FJ (2005) Obstructive sleep apnea, morbid obesity, and adenotonsillar surgery: a review of the literature. Int J Pediatr Otorhinolaryngol 69:1475–1482
Friedman M, Wilson M, Lin HC, Chang HW (2009) Updated systematic review of tonsillectomy and adenoidectomy for treatment of pediatric obstructive sleep apnea/hypopnea syndrome. Otolaryngol Head Neck Surg 140:800–808
Nolan J, Brietzke SE (2011) Systematic review of pediatric tonsil size and polysomnogram-measured obstructive sleep apnea severity. Otolaryngol Head Neck Surg 144:844–850
Major MP, Flores-Mir C, Major PW (2006) Assessment of lateral cephalometric diagnosis of adenoid hypertrophy and posterior upper airway obstruction: a systematic review. Am J Orthod Dentofac Orthop 130:700–708
Feres MF, Hermann JS, Cappellette M Jr, Pignatari SS (2011) Lateral X-ray view of the skull for the diagnosis of adenoid hypertrophy: a systematic review. Int J Pediatr Otorhinolaryngol 75:1–11
Ronen O, Malhotra A, Pillar G (2007) Influence of gender and age on upper-airway length during development. Pediatrics 120:e1028–e1034
Wing YK, Hui SH, Pak WM, Ho CK, Cheung A et al (2003) A controlled study of sleep related disordered breathing in obese children. Arch Dis Child 88:1043–1047
Tagaya M, Nakata S, Yasuma F, Miyazaki S, Sasaki F, Morinaga M et al (2012) Relationship between adenoid size and severity of obstructive sleep apnea in preschool children. Int J Pediatr Otorhinolaryngol 76:1827–1830
Dayyat E, Kheirandish-Gozal L, Sans Capdevila O, Maarafeya MM, Gozal D (2009) Obstructive sleep apnea in children: relative contributions of body mass index and adenotonsillar hypertrophy. Chest 136:137–144
Kenna MA, Amin A (2009) Anatomy and physiology of the oral cavity. In: Snow JB, Wackym PA (eds) Ballenger’s otorhinolaryngology head and neck surgery, 17th edn. BC Decker Inc, Shelton, pp 769–774
Susan S, Harold E, Jermiah CH, David J, Andrew W (2005) Pharynx (chapter 35). In: Susan S (ed) Gray’s anatomy: the anatomical basis of clinical practice, 39th edn. Elsevier, Philadelphia, pp 619–631
Brodsky L (1999) Adenotonsillar disease in children. Pract Paediatr Otolaryngol Ch 2:15–39
Richardson MA (1999) Sore throat, tonsillitis, and adenoiditis. Med Clin North Am 83:75–83
Becker W, Nauman HH, Pfaltz CR, Behrbohm H, Nawka T (2009) Ear, Nose, and Throat Diseases. In: Behrbohm H, Kaschke O, Nawka T, Swift A (eds), 3rd edn. Thieme, New York, pp 307–309, 322–324
Drake AF (2015) Tonsillectomy. In: Meyers AD (ed) Medscape. http://reference.medscape.com/article/872119-overview#showall. Accessed 3 Jan 2016
Trimble MV (2016) Adenoid and tonsil hypertrophy. http://dfwsinus.com/nasal-airway-obstruction/adenoid-tonsil-hypertrophy/. Accessed 3 Jan 2016
Peterson J, Losek JD (2004) Post-tonsillectomy hemorrhage and pediatric emergency care. Clin Pediatr (Phila) 43(5):445–448
Stuck BA, Gotte K, Windfuhr JP, Genzwurker H, Schroten H, Tenenbaum T (2008) Tonsillectomy in children. Dtsch Arztebl Int 105(49):852–860
Cataletto ME (2015) Childhood sleep apnea treatment and management. In: Bye MR (ed) Medscape. http://emedicine.medscape.com/article/1004104-treatment#d7. Accessed 2 Mar 2016
Jeong JH, Lee DW, Ryu RA, Lee YS, Lee SH, Kang JO et al (2007) Bacteriologic comparison of tonsil core in recurrent tonsillitis and tonsillar hypertrophy. Laryngoscope 117(12):2146–2151
Serpero LD, Kheirandish-Gozal L, Dayyat E, Goldman JL, Kim J, Gozal D (2009) A mixed cell culture model for assessment of proliferation in tonsillar tissues from children with obstructive sleep apnea or recurrent tonsillitis. Laryngoscope 119(5):1005–1010
Kelishadi R, Nilforoushan N, Okhovat A, Amra B, Poursafa P, Rogha M (2011) Effects of adenoidectomy on markers of endothelial function and inflammation in normal-weight and overweight prepubescent children with sleep apnea. J Res Med Sci. 16(Special Issue):386–394
Brook I, Shah K, Jackson W (2000) Microbiology of healthy and diseased adenoids. Laryngoscope 110(6):994–999
Don DM, Goldstein NA, Crockett DM, Ward SD (2005) Antimicrobial therapy for children with adenotonsillar hypertrophy and obstructive sleep apnea: a prospective randomized trial comparing azithromycin vs placebo. Otolaryngol Head Neck Surg 133(4):562–568
Sclafani AP, Ginsburg J, Shah MK, Dolitsky JN (1998) Treatment of symptomatic chronic adenotonsillar hypertrophy with amoxicillin/clavulanate potassium: short- and long-term results. Pediatrics 101(4 Pt 1):675–681
Brouillette RT, Manoukian JJ, Ducharme FM, Oudjhane K, Earle LG, Ladan S et al (2001) Efficacy of fluticasone nasal spray for pediatric obstructive sleep apnea. J Pediatr 138(6):838–844
Demain JG, Goetz DW (1995) Pediatric adenoidal hypertrophy and nasal airway obstruction: reduction with aqueous nasal beclomethasone. Pediatrics 95(3):355–364
Criscuoli G, D’Amora S, Ripa G, Cinquegrana G, Mansi N, Impagliazzo N et al (2003) Frequency of surgery among children who have adenotonsillar hypertrophy and improve after treatment with nasal beclomethasone. Pediatrics 111(3):e236–e238
Peters-Golden M, Canetti C, Mancuso P, Coffey MJ (2005) Leukotrienes:underappreciated mediators of innate immune responses. J Immunol 174:589–594
Serezani CH, Lewis C, Jancar S, Peters-Golden M (2011) Leukotriene B4 amplifies NF-κB activation in mouse macrophages by reducing SOCS1 inhibition of MyD88 expression. J Clin Invest 121:671–682
Parnes SM (2003) The role of leukotriene inhibitors in patients with paranasal sinus disease. Curr Opin Otolaryngol Head Neck Surg 11:184–191
Hui Y, Cheng Y, Smalera I, Jian W, Goldhahn L, Fitzgerald GA et al (2004) Directed vascular expression of human cysteinyl leukotriene 2 receptor modulates endothelial permeability and systemic blood pressure. Circulation 110:3360–3366
Alobid I, Cardelús S, Picado C, Mullol J (2008) Antileukotrienes in rhinosinusitis and nasal polyposis. Expert Rev Clin Immunol 4(3):331–337
Peters-Golden M, Henderson WR Jr (2007) Leukotrienes. N Engl J Med 357:1841–1854
CPAP Treatment for adults with obstructive sleep apnea: review of the clinical and cost-effectiveness and guidelines. Rapid response report: summary with critical appraisal Ottawa (ON): Canadian Agency for Drugs and Technologies in Health. http://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0064333/. Accessed 18 Nov 2013
Tsaoussoglou M, Lianou L, Maragozidis P, Hatzinikolaou S, Mavromati M, Orologas N et al (2012) Cysteinyl leukotriene receptors in tonsillar B- and T-lymphocytes from children with obstructive sleep apnea. Sleep Med 13:879–885
Goldbart AD, Greenberg-Dotan S, Tal A (2012) Montelukast for children with obstructive sleep apnea: a double-blind, placebo-controlled study. Pediatrics 130:e575–e580
Cingi C, Oğhan F, Ünlü H, Tekat A, Okuyucu Ş (2011) Efficacy of montelukast and desloratadine combination in allergic rhinitis. J Med Updates 1(1):3–16
Baççıoğlu A, Yorgancıoğlu A, Cingi C, Çuhadaroğlu Ç (2013) Role of leukotriene antagonists and antihistamines in treatment of allergic rhinitis and asthma comorbidity. J Med Updates 3(1):34–39
Goldbart AD, Goldman JL, Veling MC, Gozal D (2005) Leukotriene modifier therapy for mild sleep-disordered breathing in children. Am J Respir Crit Care Med 172:364
Kheirandish-Gozal L, Bhattacharjee R, Bandla HP, Gozal D (2014) Antiinflammatory therapy outcomes for mild OSA in children. Chest 146:88
Kheirandish L, Goldbart AD, Gozal D (2006) Intranasal steroids and oral leukotriene modifier therapy in residual sleep-disordered breathing after tonsillectomy and adenoidectomy in children. Pediatrics 117:e61
Dayyat E, Serpero LD, Kheirandish-Gozal L, Goldman JL, Snow A, Bhattacharjee R et al (2009) Leukotriene pathways and in vitro adenotonsillar cell proliferation in children with obstructive sleep apnea. Chest 135(5):1142–1149
Kaditis AG, Ioannou MG, Chaidas K, Alexopoulos EI, Apostolidou M, Apostolidis T et al (2008) Cysteinyl leukotriene receptors are expressed by tonsillar T cells of children with obstructive sleep apnea. Chest 134(2):324–331
Goldbart AD, Goldman JL, Li RC, Brittian KR, Tauman R, Gozal D (2004) Differential expression of cysteinyl leukotriene receptors 1 and 2 in tonsils of children with obstructive sleep apnea syndrome or recurrent infection. Chest 126(1):13–18
Goldbart AD, Goldman JL, Veling MC, Gozal D (2005) Leukotriene modifier therapy for mild sleep-disordered breathing in children. Am J Respir Crit Care Med 172(3):364–370
Goldbart AD, Krishna J, Li RC, Serpero LD, Gozal D (2006) Inflammatory mediators in exhaled breath condensate of children with obstructive sleep apnea syndrome. Chest 130(1):143–148
Acknowledgments
“With the exception of data collection, preparation of this paper including design and planning was supported by Continuous Education and Scientific Research Association.” There was no financial support, but only scientific support.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that there is no conflict of interest.
Rights and permissions
About this article
Cite this article
Kar, M., Altıntoprak, N., Muluk, N.B. et al. Antileukotrienes in adenotonsillar hypertrophy: a review of the literature. Eur Arch Otorhinolaryngol 273, 4111–4117 (2016). https://doi.org/10.1007/s00405-016-3983-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00405-016-3983-8